Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Preparation of siRNA-encapsulated PLGA nanoparticles for sustained release of siRNA and evaluation of encapsulation efficiency.

Pantazis P, Dimas K, Wyche JH, Anant S, Houchen CW, Panyam J, Ramanujam RP.

Methods Mol Biol. 2012;906:311-9. doi: 10.1007/978-1-61779-953-2_25.

PMID:
22791444
2.

DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism.

Sureban SM, May R, Lightfoot SA, Hoskins AB, Lerner M, Brackett DJ, Postier RG, Ramanujam R, Mohammed A, Rao CV, Wyche JH, Anant S, Houchen CW.

Cancer Res. 2011 Mar 15;71(6):2328-38. doi: 10.1158/0008-5472.CAN-10-2738. Epub 2011 Feb 1.

3.

Identification of a novel putative pancreatic stem/progenitor cell marker DCAMKL-1 in normal mouse pancreas.

May R, Sureban SM, Lightfoot SA, Hoskins AB, Brackett DJ, Postier RG, Ramanujam R, Rao CV, Wyche JH, Anant S, Houchen CW.

Am J Physiol Gastrointest Liver Physiol. 2010 Aug;299(2):G303-10. doi: 10.1152/ajpgi.00146.2010. Epub 2010 Jun 3.

4.

Doublecortin and CaM kinase-like-1 and leucine-rich-repeat-containing G-protein-coupled receptor mark quiescent and cycling intestinal stem cells, respectively.

May R, Sureban SM, Hoang N, Riehl TE, Lightfoot SA, Ramanujam R, Wyche JH, Anant S, Houchen CW.

Stem Cells. 2009 Oct;27(10):2571-9. doi: 10.1002/stem.193.

5.

14-3-3sigma-dependent resistance to cisplatin.

Han Z, Dimas K, Tian X, Wang Y, Hemmi H, Yamada K, Kato N, Pantazis P, Ramanujam RJ, Anant S, Wyche JH, Houchen CW.

Anticancer Res. 2009 Jun;29(6):2009-14.

6.

A mastic gum extract induces suppression of growth of human colorectal tumor xenografts in immunodeficient mice.

Dimas K, Hatziantoniou S, Wyche JH, Pantazis P.

In Vivo. 2009 Jan-Feb;23(1):63-8.

7.

Metabolism and anticancer activity of the curcumin analogue, dimethoxycurcumin.

Tamvakopoulos C, Dimas K, Sofianos ZD, Hatziantoniou S, Han Z, Liu ZL, Wyche JH, Pantazis P.

Clin Cancer Res. 2007 Feb 15;13(4):1269-77.

8.

Sclareol induces apoptosis in human HCT116 colon cancer cells in vitro and suppression of HCT116 tumor growth in immunodeficient mice.

Dimas K, Hatziantoniou S, Tseleni S, Khan H, Georgopoulos A, Alevizopoulos K, Wyche JH, Pantazis P, Demetzos C.

Apoptosis. 2007 Apr;12(4):685-94.

PMID:
17260186
9.

Proteasome-independent down-regulation of estrogen receptor-alpha (ERalpha) in breast cancer cells treated with 4,4'-dihydroxy-trans-stilbene.

Balan KV, Wang Y, Chen SW, Chen JC, Zheng LF, Yang L, Liu ZL, Pantazis P, Wyche JH, Han Z.

Biochem Pharmacol. 2006 Aug 28;72(5):573-81. Epub 2006 Jul 5. Erratum in: Biochem Pharmacol. 2007 Jan 1;73(1):163-4.

PMID:
16822479
10.

Down-regulation of estrogen receptor-alpha in MCF-7 human breast cancer cells after proteasome inhibition.

Balan KV, Wang Y, Chen SW, Pantazis P, Wyche JH, Han Z.

Biochem Pharmacol. 2006 Aug 28;72(5):566-72. Epub 2006 Jun 27.

PMID:
16806088
11.

Antiproliferative activity and induction of apoptosis in human colon cancer cells treated in vitro with constituents of a product derived from Pistacia lentiscus L. var. chia.

Balan KV, Prince J, Han Z, Dimas K, Cladaras M, Wyche JH, Sitaras NM, Pantazis P.

Phytomedicine. 2007 Apr;14(4):263-72. Epub 2006 May 18.

PMID:
16713222
12.

Differential susceptibility to etoposide in clones derived from a human ovarian cancer cell line.

Balan KV, Sitaras NM, Dimas K, Han Z, Wyche JH, Pantazis P.

Chemotherapy. 2006;52(3):137-46. Epub 2006 Apr 26.

PMID:
16645270
13.

Induction of apoptosis in human colon cancer HCT116 cells treated with an extract of the plant product, Chios mastic gum.

Balan KV, Demetzos C, Prince J, Dimas K, Cladaras M, Han Z, Wyche JH, Pantazis P.

In Vivo. 2005 Jan-Feb;19(1):93-102.

14.

FADD-dependent apoptosis induction in Jurkat leukemia T-cells by the resveratrol analogue, 3,4,5-trihydroxy-trans-stilbene.

Wang Y, Wang B, Cheng J, Yang L, Liu ZL, Balan K, Pantazis P, Wyche JH, Han Z.

Biochem Pharmacol. 2005 Jan 15;69(2):249-54. Epub 2004 Nov 5.

PMID:
15627477
15.

Reduction of 9-nitrocamptothecin-triggered apoptosis in DU-145 human prostate cancer cells by ectopic expression of 14-3-3zeta.

Chatterjee D, Goldman M, Braastad CD, Darnowski J, Wyche JH, Pantazis P, Goodglick L.

Int J Oncol. 2004 Aug;25(2):503-9.

PMID:
15254750
16.

The 3,4-dihydroxyl groups are important for trans-resveratrol analogs to exhibit enhanced antioxidant and apoptotic activities.

Cai YJ, Wei QY, Fang JG, Yang L, Liu ZL, Wyche JH, Han Z.

Anticancer Res. 2004 Mar-Apr;24(2B):999-1002.

17.

RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis.

Chatterjee D, Bai Y, Wang Z, Beach S, Mott S, Roy R, Braastad C, Sun Y, Mukhopadhyay A, Aggarwal BB, Darnowski J, Pantazis P, Wyche J, Fu Z, Kitagwa Y, Keller ET, Sedivy JM, Yeung KC.

J Biol Chem. 2004 Apr 23;279(17):17515-23. Epub 2004 Feb 6.

20.

Helix 6 of tBid is necessary but not sufficient for mitochondrial binding activity.

Hu X, Han Z, Wyche JH, Hendrickson EA.

Apoptosis. 2003 Jun;8(3):277-89.

PMID:
12766488
21.

The antibacterial drug taurolidine induces apoptosis by a mitochondrial cytochrome c-dependent mechanism.

Han Z, Ribbizi I, Pantazis P, Wyche J, Darnowski J, Calabresi P.

Anticancer Res. 2002 Jul-Aug;22(4):1959-64.

PMID:
12174870
22.

Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin.

Han Z, Wei W, Dunaway S, Darnowski JW, Calabresi P, Sedivy J, Hendrickson EA, Balan KV, Pantazis P, Wyche JH.

J Biol Chem. 2002 May 10;277(19):17154-60. Epub 2002 Mar 4.

23.

Cathepsin B and complement C3 are major comigrants in the estrogen-induced peroxidase fraction of rat uterine fluid.

Balan KV, Hollis VW, Eckberg WR, Ayorinde F, Karkera JD, Wyche JH, Anderson WA.

J Submicrosc Cytol Pathol. 2001 Jul;33(3):221-30.

PMID:
11846090
24.

Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation.

Yeung KC, Rose DW, Dhillon AS, Yaros D, Gustafsson M, Chatterjee D, McFerran B, Wyche J, Kolch W, Sedivy JM.

Mol Cell Biol. 2001 Nov;21(21):7207-17.

25.

Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short).

Chatterjee D, Schmitz I, Krueger A, Yeung K, Kirchhoff S, Krammer PH, Peter ME, Wyche JH, Pantazis P.

Cancer Res. 2001 Oct 1;61(19):7148-54.

26.

A Fas-associated death domain protein-dependent mechanism mediates the apoptotic action of non-steroidal anti-inflammatory drugs in the human leukemic Jurkat cell line.

Han Z, Pantazis P, Wyche JH, Kouttab N, Kidd VJ, Hendrickson EA.

J Biol Chem. 2001 Oct 19;276(42):38748-54. Epub 2001 Aug 20.

27.

9-Nitrocamptothecin is an effective drug for the treatment of human lung tumors: comparison of in vitro and in vivo studies.

Han Z, Wyche JH, Sands H, Pantazis P.

Anticancer Res. 2001 May-Jun;21(3B):1823-7.

PMID:
11497265
28.

c-Myc is necessary for DNA damage-induced apoptosis in the G(2) phase of the cell cycle.

Adachi S, Obaya AJ, Han Z, Ramos-Desimone N, Wyche JH, Sedivy JM.

Mol Cell Biol. 2001 Aug;21(15):4929-37.

29.

Up-regulation of cyclin B1 and cdc2 expression during 9-nitrocamptothecin-induced regression of DU145 prostate tumor.

Chatterjee D, Wyche JH, Pantazis P.

Anticancer Res. 2000 Nov-Dec;20(6B):4477-82.

PMID:
11205291
30.
31.

Telomerase activity, Myc and Bcl-2: possible indicators of effective therapy of prostate cancer with 9-nitrocamptothecin.

Chatterjee D, Wyche JH, Romero DP, Pantazis P.

Anticancer Res. 2000 Sep-Oct;20(5A):2885-9.

PMID:
11062697
32.

Susceptibility to apoptosis is restored in human leukemia HCW-2 cells following induction and stabilization of the apoptotic effector Bak.

Chatterjee D, Pantazis P, Li G, Bremner TA, Hendrickson EA, Wyche JH.

Oncogene. 2000 Aug 24;19(36):4108-16.

33.
34.

The staurosporine analog, Ro-31-8220, induces apoptosis independently of its ability to inhibit protein kinase C.

Han Z, Pantazis P, Lange TS, Wyche JH, Hendrickson EA.

Cell Death Differ. 2000 Jun;7(6):521-30.

35.

THP-1 monocytic leukemia cells express Fas ligand constitutively and kill Fas-positive Jurkat cells.

Bremner TA, Chatterjee D, Han Z, Tsan MF, Wyche JH.

Leuk Res. 1999 Oct;23(10):865-70.

PMID:
10573130
36.

Schedule-dependent efficiency of thermochemotherapy in vitro with etoposide and heating at 43 degrees C.

Pantazis P, Han Z, Wyche J.

Anticancer Res. 1999 Mar-Apr;19(2A):995-8.

PMID:
10368644
37.

Apoptosis and differentiation in the crypt-villus unit of the rat small intestine.

Westcarr S, Farshori P, Wyche J, Anderson WA.

J Submicrosc Cytol Pathol. 1999 Jan;31(1):15-30.

PMID:
10363352
38.

Modulation of 9-nitrocamptothecin-induced apoptosis by hyperthermia in human leukemia HL-60 cells.

Pantazis P, Chatterjee D, Han Z, Wyche J.

Anticancer Drugs. 1999 Mar;10(3):317-22.

PMID:
10327039
39.

Propionate and butyrate esters of camptothecin and 9-nitrocamptothecin as antileukemia prodrugs in vitro.

Han Z, Cao Z, Chatterjee D, Wyche J, Pantazis P.

Eur J Haematol. 1999 Apr;62(4):246-55.

PMID:
10227458
40.

A cytosolic factor is required for mitochondrial cytochrome c efflux during apoptosis.

Han Z, Li G, Bremner TA, Lange TS, Zhang G, Jemmerson R, Wyche JH, Hendrickson EA.

Cell Death Differ. 1998 Jun;5(6):469-79.

41.

Water-insoluble camptothecin analogues as potential antiviral drugs.

Pantazis P, Han Z, Chatterjee D, Wyche J.

J Biomed Sci. 1999 Jan;6(1):1-7. Review.

PMID:
9933736
42.
43.

Overexpression of bcl-2 or bcl-XL fails to inhibit apoptosis mediated by a novel retinoid.

Fontana JA, Sun RJ, Rishi AK, Dawson MI, Ordónez JV, Zhang Y, Tschang SH, Bhalla K, Han Z, Wyche J, Poirer G, Sheikh MS, Shroot B, Reichert U.

Oncol Res. 1998;10(6):313-24.

PMID:
9848102
44.

Monocytic differentiation of HL-60 promyelocytic leukemia cells correlates with the induction of Bcl-xL.

Chatterjee D, Han Z, Mendoza J, Goodglick L, Hendrickson EA, Pantazis P, Wyche JH.

Cell Growth Differ. 1997 Oct;8(10):1083-9.

45.

Extracellular ATP and adenosine cause apoptosis of pulmonary artery endothelial cells.

Dawicki DD, Chatterjee D, Wyche J, Rounds S.

Am J Physiol. 1997 Aug;273(2 Pt 1):L485-94.

PMID:
9277463
46.

A sequential two-step mechanism for the production of the mature p17:p12 form of caspase-3 in vitro.

Han Z, Hendrickson EA, Bremner TA, Wyche JH.

J Biol Chem. 1997 May 16;272(20):13432-6.

47.
48.

Estrogen receptor, growth factor receptor and protooncogene protein activities and possible signal transduction crosstalk in estrogen dependent and independent breast cancer cell lines.

Mohamood AS, Gyles P, Balan KV, Hollis VW, Eckberg WR, Asseffa A, Han Z, Wyche JH, Anderson WA.

J Submicrosc Cytol Pathol. 1997 Jan;29(1):1-17.

PMID:
9066137
49.

Induction of apoptosis in malignant and camptothecin-resistant human cells.

Chatterjee D, Wyche JH, Pantazis P.

Ann N Y Acad Sci. 1996 Dec 13;803:143-56.

PMID:
8993507
50.

DNA-dependent protein kinase is a target for a CPP32-like apoptotic protease.

Han Z, Malik N, Carter T, Reeves WH, Wyche JH, Hendrickson EA.

J Biol Chem. 1996 Oct 4;271(40):25035-40.

Supplemental Content

Support Center